2006
DOI: 10.1016/j.jaut.2006.09.008
|View full text |Cite
|
Sign up to set email alerts
|

Reduced flow-mediated vasodilation as a marker for cardiovascular complications in lupus patients

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

5
49
1
2

Year Published

2007
2007
2017
2017

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 78 publications
(57 citation statements)
references
References 35 publications
5
49
1
2
Order By: Relevance
“…Consistent with this notion, other chronic inflammatory immune disorders have been identified as independent risk factors for CVD. Recent studies have demonstrated that patients with psoriasis arthritis (PsA) [28], RA [16][17][18] and SLE [19][20][21], have impaired endothelial function reflecting an early stage of atherosclerosis [29,30]. The endothelial dysfunction seems to appear prior to any overt CVD and in the absence of classic cardiovascular risk factors, indicating that systemic inflammatory, a key feature in PsA, RA and SLE, may play a pivotal role in the increased prevalence of cardiovascular complications in these patients.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Consistent with this notion, other chronic inflammatory immune disorders have been identified as independent risk factors for CVD. Recent studies have demonstrated that patients with psoriasis arthritis (PsA) [28], RA [16][17][18] and SLE [19][20][21], have impaired endothelial function reflecting an early stage of atherosclerosis [29,30]. The endothelial dysfunction seems to appear prior to any overt CVD and in the absence of classic cardiovascular risk factors, indicating that systemic inflammatory, a key feature in PsA, RA and SLE, may play a pivotal role in the increased prevalence of cardiovascular complications in these patients.…”
Section: Discussionmentioning
confidence: 99%
“…Both RA and SLE are associated with endothelial dysfunction [16][17][18][19][20][21]. Flow-mediated vasodilatation (FMD) of the brachial artery by using a high resolution ultrasound is a non-invasive and extensively validated method for assessing systemic endothelial function.…”
Section: Introductionmentioning
confidence: 99%
“…Kiss et al (16 ) showed that FMD percentages were significantly lower in patients with systemic lupus erythematosus than in the control group. Low percentage of FMD was also found in patients with rheumatoid arthritis because 62 of chronic inflammation (17-18).…”
Section: Discussionmentioning
confidence: 98%
“…Techniques designed to assess endothelial function are based on measurement of brachial artery reactivity in response to changes in blood-flow caused by passive congestion (flow-mediated vasodilatation, which is dependent on endothelial function) (Corretti et al, 2002). Studies performed in SLE patients documented an impaired endothelial function and this fact was attributed to reduced nitric oxide bioavailability resulting from increased oxidative stress in the course of SLE (El-Magadmi et al, 2004;Kiss et al, 2006;Wright et al, 2006). Furthermore, impairment of endothelial function remained significant even after adjustment for other classic atherosclerosis risk factors and the authors suggested that SLE is an independent risk factor for endothelial dysfunction (El-Magadmi et al, 2004).…”
Section: Atherosclerosis In Systemic Lupus Erythematosus -The Backgroundmentioning
confidence: 99%